Autres langues GlycoMimetics, Inc.

Actions

GLYC

US38000Q1022

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
1,62 ^USD	-10,00%		-12,67%	-31,36%

27/03	Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
27/03	GlycoMimetics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024	25/04
GlycoMimetics: Q4 Earnings Snapshot	27/03
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023	27/03
GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
GlycoMimetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024	13/03
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference	26/02
GlycoMimetics Reports Inducement Grant under NASDAQ Listing Rule 5635(4)	13/02
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	12/02
GlycoMimetics, Inc. Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1A Healthy Volunteer Study of GMI-1687	04/01
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687	04/01
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	03/01
GlycoMimetics, Thermo Fisher Unit Set Accord for Manufacturing Uproleselan for Acute Myeloid Leukemia	02/01
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	10/12
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference	09/11
GlycoMimetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
GlycoMimetics: Q3 Earnings Snapshot	03/11
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023	03/11
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	23/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GlycoMimetics, Inc.

Actions

GLYC

US38000Q1022

Autres langues

Filtres